Epidemiological Research on SARS-CoV-2 (novel coronavirus) Antibody Positivity Rate among Healthcare Workers at Saitama Medical Center, Jichi Medical University

Epidemiological Research on SARS-CoV-2 (novel coronavirus) Antibody Positivity Rate among Healthcare Workers at Saitama Medical Center, Jichi Medical University - Epidemiological Research on SARS-CoV-2 Antibody Positivity Rate among Healthcare Workers at Saitama Medical Center, Jichi Medical University

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044650

Enrollment

400

Registered

2021-06-30

Start date

2020-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy medical personnel who are engaged in this hospital and who have given consent to this research

Exclusion criteria

Exclusion criteria: Those with symptoms of COVID-19 within 2 weeks of the test, and those who do not consent to the research

Design outcomes

Primary

Measure	Time frame
The primary outcome is the difference between the antibody-positive rate among all research subjects and the rate among COVID-19 practitioners	—

Secondary

Measure	Time frame
The secondary outcome is the detection of significant differences in each factor between antibody-positive and antibody-negative subjects (Age, gender, place of residence, department, presence of COVID19 in the patient in charge, travel history in the last year, access to cluster-infected areas, the common cold symptoms and fever within 4 months)	—

Countries

Japan

Contacts

Public ContactHitoshi Sugawara

Saitama Medical Center, Jichi Medical University General Medicine

hsmdfacp@jichi.ac.jp0486472111

Outcome results